CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis

Overview of attention for article published in BMC Cancer, April 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 38 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

BIOMARKERS FOR ENDOMETRIAL CANCER

Application WO-2023002039-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.